Treprostinil 200 mg/20mL (Treprostinil INJECTION) 200 mg/20mL

Treprostinil 200 mg/20mL is a medication used for specific medical conditions. This injection is designed for intravenous or subcutaneous administration, offering a versatile treatment option.

Strength

200 mg/20mL

Pack Size

1 VIAL, MULTI-DOSE in 1 CARTON (0781-3430-80) / 20 mL in 1 VIAL, MULTI-DOSE

Manufacturer / TM Owner

Sandoz Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Treprostinil is primarily used to manage certain cardiovascular and pulmonary conditions. It is often prescribed for conditions that require vasodilation or improved blood flow. Patients may wonder, 'What is treprostinil used for?' This medication is typically utilized in scenarios where maintaining vascular health is crucial.

Side Effects

Treprostinil can cause various effects, including changes in blood pressure and heart rate. Some users may experience side effects such as headache, nausea, or injection site reactions. It is important to monitor these effects closely.

Precautions & Warnings

When handling treprostinil, it is essential to follow proper injection techniques to minimize the risk of infection. Store the medication as directed to maintain its efficacy. Always consult a healthcare provider before starting any new medication.

Avoid Interactions

Treprostinil may interact with other medications, including those that affect blood pressure or heart rate. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how treprostinil works.

Frequently Asked Questions

Treprostinil is used to manage certain cardiovascular and pulmonary conditions, often involving vasodilation or improved blood flow.

Treprostinil can be administered intravenously or subcutaneously, depending on the specific medical condition being treated.

Common side effects may include headache, nausea, and reactions at the injection site. Always monitor for any adverse effects.

Yes, treprostinil may interact with medications that affect blood pressure or heart rate. Always consult a healthcare provider before combining treatments.

Treprostinil should be stored according to the manufacturer's instructions to maintain its effectiveness and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.